Diagnostyka revenue and financials
zł 159.40Change from previous close: −0.75%Absolute change: −zł 1.20
In the fiscal year ended December 2025, Diagnostyka reported revenue of zł 2.41B (+23.60% year over year). Net income was zł 251.6M, a net margin of 10.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +23.60%
- 2025 vs 2024
- Net income growth
- +12.66%
- 2025 vs 2024
- Net margin
- 10.4%
- 2024: 11.5%
Financial data
Amounts in millions of PLN; per-share values in PLN; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 683 | 671 | 618 | 612 | 588 | — |
| Cost of revenue | 152 | 139 | 137 | 124 | 121 | — |
| Gross profit | 531 | 532 | 481 | 488 | 468 | — |
| Operating income | 95.3 | 124 | 67.6 | 101 | 102 | — |
| EBIT | 95.4 | 125 | 68.3 | 101 | 103 | — |
| EBITDA | 155 | 181 | 121 | 153 | 153 | — |
| Interest expense | 16.3 | 16.6 | 19.4 | 16.9 | 16.4 | — |
| Pre-tax income | 79.2 | 108 | 48.9 | 84.3 | 86.5 | — |
| Income tax | 18.7 | 22.2 | 9.6 | 3.6 | 19.8 | — |
| Net income | 57.4 | 82.6 | 36.9 | 78.1 | 63.8 | — |
| Net income to common shareholders | 57.4 | 82.6 | 36.9 | 78.1 | 63.8 | — |
| Basic EPS | 1.70 | 2.45 | — | 2.31 | 1.89 | 2.16 |
| Diluted EPS | 1.70 | 2.45 | — | 2.31 | 1.89 | 2.16 |
| Average shares (basic) | 33.8 | 33.7 | — | 33.8 | 33.8 | 33.7 |
| Average shares (diluted) | 33.8 | 33.7 | — | 33.8 | 33.8 | 33.7 |